Table 1.
Baseline characteristics for the intervention group (gPCC-G) and the control group (CG)
| Variable | gPCC-G n = 54 |
CG n = 42 |
|---|---|---|
| Age Mean (at baseline) (SD) | 61 (7.8) | 62 (10.5) |
| Male (%) | 70 | 69 |
| Employed (yes) (%) | 67 | 41 |
| Living with someone (%) | 80 | 88 |
| Tumor site: (%) | ||
| Oropharynx | 65 | 76 |
| Larynx | 11 | 14 |
| Neck node with unknown primary | 6 | 5 |
| Hypopharynx | 6 | 0 |
| Oral cavity | 4 | 5 |
| Parotid gland | 4 | 0 |
| Paranasal sinus | 2 | 0 |
| Nasopharynx | 2 | 0 |
| Clinical stage: (%) | ||
| I | 5 | 12 |
| II | 13 | 7 |
| III | 19 | 19 |
| IV | 63 | 62 |
| Treatment: (%) | ||
| Chemo radiotherapy | 72 | 76 |
| Primary radiation | 28 | 24 |
| HPV positive (%) | 68 | 62 |
| HPV negative (%) | 13 | 26 |
| HPV not known (%) | 19 | 12 |
Values are mean, standard deviation (SD) and %
HPV Human papillomavirus